Forefront Analytics’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$518K Buy
5,043
+1,287
+34% +$145K 0.47% 17
2025
Q4
$471K Buy
3,756
+744
+25% +$94.8K 0.42% 25
2025
Q3
$403K Buy
3,012
+119
+4% +$15.6K 0.39% 24
2025
Q2
$394K Buy
+2,893
New +$381K 0.44% 24
2025
Q1
Sell
-2,683
Closed -$304K 46
2024
Q4
$304K Sell
2,683
-1,200
-31% -$139K 0.14% 48
2024
Q3
$443K Buy
+3,883
New +$426K 0.21% 46
2023
Q2
Sell
-3,009
Closed -$305K 66
2023
Q1
$305K Buy
3,009
+383
+15% +$40.4K 0.16% 54
2022
Q4
$289K Buy
+2,626
New +$272K 0.15% 53
2020
Q2
Sell
-35
Closed -$2.76K 54
2020
Q1
$2.76K Buy
+35
New +$2.92K ﹤0.01% 100

Other funds holding ABT

Forefront Analytics's ABT Position: Q1 2026 in Review

Forefront Analytics increased its Abbott (ABT) stake by 34% in Q1 2026, buying an estimated $145K and bringing the position to 5,043 shares worth $518K. The position accounts for 0.47% of the portfolio, ranked #17.

Forefront Analytics first reported a position in ABT in Q1 2020 and has held it in 9 quarters since. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Forefront Analytics held 5,043 shares of Abbott worth $518K as of Q1 2026.
  • Forefront Analytics bought 1,287 Abbott shares in Q1 2026, an estimated $145K.
  • Abbott made up 0.47% of Forefront Analytics's portfolio in Q1 2026, its #17 holding.
  • Forefront Analytics first reported a position in Abbott in Q1 2020 and has held it in 9 quarters since.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Forefront Analytics's 13F filing for Q1 2026, filed 13 May 2026.